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Brief Research Summary (PAO): Validation of Procedures for Monitoring Crew Member Immune 
Function (Integrated Immune) will assess the clinical risks resulting from the adverse effects of space 
flight on the human immune system and will validate a flight-compatible immune monitoring strategy. 
Researchers will collect and analyze blood, urine and saliva samples from crewmembers before, during 
and after space flight to monitor changes in the immune system. Changes in the immune system will be 
monitored by collecting and analyzing blood and saliva samples from crewmembers during flight and 
blood, urine, and saliva samples before and after space flight.  
Research Summary:  
• There is ample postflight evidence to suggest that space flight has a negative effect on the 
immune system however, little inflight data has been collected. The inflight data that exists 
suggests immune dysregulation occurs during flight. There are several possible causes ranging 
from microgravity to stress to radiation. Complications arising from an immune system 
dysregulation have the potential to pose a clinical risk for exploration class space missions. 
• In order to develop countermeasures to reduce inflight immune dysfunction, a monitoring strategy 
must be developed. 
• The objective of this study is to validate a monitoring strategy that will allow future 
countermeasures to be developed. 
https://ntrs.nasa.gov/search.jsp?R=20080009760 2019-08-30T03:52:44+00:00Z
Detailed Research Description: The Validation of Procedures for Monitoring Crewmember Immune 
Function - Short Duration Biological Investigation (Integrated Immune) is to develop and validate an 
immune monitoring strategy consistent with operational flight requirements and constraints. There are no 
procedures currently in place to monitor immune function or its influence on crew health. Immune 
dysregulation has been demonstrated to occur during space flight, yet precious little inflight immune data 
has been generated to assess this clinical problem. Integrated Immune assesses the clinical risks 
resulting from the adverse effects of space flight on the human immune system and will validate a flight-
compatible immune monitoring strategy. Characterization of the clinical risk and the development of a 
monitoring strategy are necessary prerequisite activities prior to validating countermeasures. 
 
Preflight, inflight and postflight assessments will be performed. The inflight samples will allow a distinction 
between legitimate inflight alterations and the physiological stresses of landing which are believed to alter 
landing day assessments. The overall status of the immune system during flight (activation, deficiency, 
dysregulation) and the response of the immune system to specific latent virus reactivation (known to 
occur during space flight) will be thoroughly assessed. 
 
Following completion of the investigation, the data will be evaluated to determine the optimal set of 
assays for routine monitoring of crewmember immune system function. It is intended that the determined 
set of relevant assays will be incorporated into the Clinical Status Evaluation (CSE) and utilized to monitor 
the effectiveness of human medical countermeasures related to immune function (exercise, medication, 
diet regulation-supplementation, immune modulators, etc.). In addition, the assays validated here will 
have significant benefit for the routine monitoring of crewmember's immune system status with regard to 
diagnosis and prognosis of immune-related disease states.  
Project Type: Payload  
Images and Captions: 
 
The image above is the kit that contains all the items the crew will need for taking blood samples. Image 
courtesy of NASA, Johnson Space Center.  
 
 
Pictured here is the kit that will be used to collect the saliva samples. In the upper left of the image the 
rolled gaze is seen; this will be place into the mouth to absorb saliva. Image courtesy of NASA, Johnson 
Space Center.  
 
Operations Location: ISS Inflight  
Brief Research Operations:  
• Preflight and postflight activities include collecting blood, urine and saliva samples at certain 
timepoints depending on whether the crewmembers are participating on short- or long-duration 
missions. 
• Shuttle crewmembers will collect a saliva sample every other day for the duration of their mission 
with a blood draw occurring on the day before they land. 
• ISS crewmembers will perform three sessions (early, mid and late mission) in which they will 
collect blood and saliva samples. 
• For both Shuttle and ISS subjects, all inflight samples are returned to the ground for analysis. 
Operational Requirements: Preflight, each subject performs two sessions: one at L-180 (launch minus 
180) days and another at L-45 days. Each session consists of four liquid saliva collections (performed 
every other day), with the blood draw, 24-hour urine and dry book saliva sample collection occurring on 
the day between the 2nd and 3rd liquid saliva collection. 
 
Postflight, each subject performs two sessions: one at R+0 collecting four liquid saliva samples collected 
every other day starting on R+0 in conjunction with a blood draw and 24-hour urine collection. The 
second session two occurs at R+ 30 days collecting four liquid saliva samples (performed every other 
day) with a blood draw and 24-hour urine collection occurring on the day between the second and third 
liquid saliva collections. Dry book saliva samples are collected on R+1 and R+ 30 days. 
 
Inflight, only blood and saliva samples are collected. There is no urine sample requirement for inflight 
operations. Subjects perform three sessions in-flight: early, mid and late increment. Each session consists 
of four liquid saliva collections (performed every other day), with a blood draw and dry book saliva sample 
collection occurring on the last day of the liquid saliva collections. For the late increment session, the final 
liquid saliva sample, the blood draw and dry book saliva sample collections occur on R-1. Blood samples 
are required to be returned for ground analysis within 48 hours of collection, therefore, the blood draws 
must occur in conjunction with a Shuttle or Soyuz flight to ISS.  
Operational Protocols: Operations for this experiment consist of three types of sample collections: blood, 
urine and saliva. There are two types of saliva samples collected. Liquid saliva samples require the 
subject to soak a piece of cotton with saliva and place the cotton in a salivette bag. Dry book saliva 
samples are collected on filter paper bound in a small, specialized book at certain time intervals 
throughout the collection day. For preflight and postflight BDC only, 24-hour urine collections require the 
subject to collect all urine starting with the first void of the day and continuing for a full 24-hour period.  
Review Cycle Status: PI Reviewed  
Category: Human Research and Countermeasure Development for Exploration  
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Space Applications: The study will result in the validation of a monitoring strategy that will allow the 
development of effective countermeasures, which, when implemented, will safeguard the health of the 
crew during long duration space missions.  
Earth Applications: The data collected during this investigation may lead a greater understanding of 
how the immune system is affected by different factors from stress to the environment. This data could 
potentially be used to help develop new treatments and preventative measures for immune dysfunctions.  
Manifest Status: Continuing  
Supporting Organization: Exploration Systems Mission Directorate (ESMD)  
Previous Missions: Increment 16 was the first mission for Integrated Immune.  
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